Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Rockwell Medical, Inc. (RMTI)

NCM · Drug Manufacturers - Specialty & Generic

$6.99-0.01 (-0.14%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$27.6M
P/E (TTM)
EPS
$-1.47
Div Yield
52W Range
$4.89–$21.00
Beta
1.61

Company overview

Next earnings: 2026-08-13(16d)

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

April 2026

3 months agoPRE 14AHealthcare

RMTI shareholders vote on reverse stock split and board changes

RMTIROCKWELL MEDICAL, INC.

# 📋 What This Document Is 📝 This document is a Preliminary Proxy Statement (Schedule 14A), which is a formal report filed with the SEC. Think of it as the comprehensive instruction manual for shareholders, explaining everything that will be decided at the company's annual meeting. 📖 The purpose

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

Rockwell Medical, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
1,396,990 sh+3.2%
468,320 sh-16.7%
UBS Group AG$116,523
139,715 sh+1749.8%
125,691 sh● NEW
101,079 sh● NEW
364,816 sh+12.9%
220,696 sh-0.7%
100,904 sh0.0%

People at Rockwell Medical, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$18.6M
NI -$1.5M
06/25
NI -$1.5M
09/25
$15.9M
NI -$1.8M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.05
Prior: $-0.05
Revenue sparkline